Cigna Group (CI)

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

We believe that aligning executive compensation to the achievement of enterprise goals that support our mission and our business strategy and drive innovation to improve access to and affordability of health care will result in the creation of meaningful and sustained long-term value benefiting our customers, patients, providers, clients, shareholders, and other stakeholders.

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

a. Approved under the standard stated in the filing — “2 Advisory approval of executive compensation Majority of shares present and entitled to vote on the subject matter Counted "against" Not voted/No effect”.

b. Approved under the standard stated in the filing — “114 The Cigna Group | 2025 Notice of Annual Meeting of Shareholders and Proxy Statement ANNUAL MEETING INFORMATION Management Proposal / Item Vote Required for Approval Effect of Abstentions Effect of Broker Non-Votes 1 Election of eleven director nominees named in this Proxy Statement Majority of votes cast No effect Not voted/No effect 2 Advisory approval of executive compensation Majority of shares present and entitled to vote on the subject matter Counted "against" Not voted/No effect 3 Ratification of the appointment of the appointment of independent auditor Majority of shares present and entitled to vote on the subject matter Counted "against" No broker non-votes;”.

c. Approved under the standard stated in the filing — “The Cigna Group | 2024 Notice of Annual Meeting of Shareholders and Proxy Statement 131 ANNUAL MEETING INFORMATION Management Proposal / Item Vote Required for Approval Effect of Abstentions Effect of Broker Non-Votes 1 Election of twelve director nominees named in this Proxy Statement Majority of votes cast No effect Not voted/No effect 2 Advisory approval of executive compensation Majority of shares present and entitled to vote on the subject matter Counted "against" Not voted/No effect 3 Ratification of the appointment of the appointment of independent auditor Majority of shares present and entitled to vote on the subject matter Counted "against" No broker non-votes;”.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

Of the companies Cigna Group names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.

Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Cigna Group.

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.